The stock of Verastem Inc (VSTM) has gone up by 47.82% for the week, with a 47.45% rise in the past month and a 136.88% rise in the past quarter. The volatility ratio for the week is 12.77%, and the volatility levels for the past 30 days are 9.99% for VSTM. The simple moving average for the last 20 days is 36.14% for VSTM stock, with a simple moving average of -3.05% for the last 200 days.
Is It Worth Investing in Verastem Inc (NASDAQ: VSTM) Right Now?
The stock has a 36-month beta value of 0.22. Opinions on the stock are mixed, with 7 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for VSTM is 39.12M, and at present, short sellers hold a 6.02% of that float. On December 03, 2024, the average trading volume of VSTM was 917.42K shares.
VSTM) stock’s latest price update
Verastem Inc (NASDAQ: VSTM) has seen a rise in its stock price by 4.71 in relation to its previous close of 5.52. However, the company has experienced a 47.82% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2024-11-27 that Verastem’s avutometinib and defactinib show promising clinical progress for recurrent KRAS-mutant LGSOC, with potential FDA approval and market launch by mid-2025. The company’s strong cash position and strategic focus on RAS-driven cancers offer significant growth opportunities without imminent dilution risks. Upcoming catalysts include FDA filing decisions, interim data from NSCLC and pancreatic cancer trials, and potential commercial launch, driving Verastem’s bullish outlook.
Analysts’ Opinion of VSTM
Many brokerage firms have already submitted their reports for VSTM stocks, with Guggenheim repeating the rating for VSTM by listing it as a “Buy.” The predicted price for VSTM in the upcoming period, according to Guggenheim is $13 based on the research report published on September 30, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see VSTM reach a price target of $27. The rating they have provided for VSTM stocks is “Buy” according to the report published on November 21st, 2023.
B. Riley Securities gave a rating of “Buy” to VSTM, setting the target price at $21 in the report published on September 27th of the previous year.
VSTM Trading at 61.68% from the 50-Day Moving Average
After a stumble in the market that brought VSTM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.35% of loss for the given period.
Volatility was left at 9.99%, however, over the last 30 days, the volatility rate increased by 12.77%, as shares surge +45.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +107.30% upper at present.
During the last 5 trading sessions, VSTM rose by +45.27%, which changed the moving average for the period of 200-days by -54.38% in comparison to the 20-day moving average, which settled at $4.24. In addition, Verastem Inc saw -28.99% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VSTM starting from Paterson Dan, who sale 812 shares at the price of $3.84 back on Nov 05 ’24. After this action, Paterson Dan now owns 231,576 shares of Verastem Inc, valued at $3,118 using the latest closing price.
Calkins Daniel, the Chief Financial Officer of Verastem Inc, sale 6 shares at $2.86 during a trade that took place back on Oct 07 ’24, which means that Calkins Daniel is holding 47,461 shares at $17 based on the most recent closing price.
Stock Fundamentals for VSTM
Current profitability levels for the company are sitting at:
- -11.32 for the present operating margin
- 1.0 for the gross margin
The net margin for Verastem Inc stands at -9.24. The total capital return value is set at -1.29. Equity return is now at value -136.87, with -61.78 for asset returns.
Based on Verastem Inc (VSTM), the company’s capital structure generated 0.79 points at debt to capital in total, while cash flow to debt ratio is standing at -2.69. The debt to equity ratio resting at 3.68. The interest coverage ratio of the stock is -25.24.
Currently, EBITDA for the company is -83.17 million with net debt to EBITDA at 0.81. When we switch over and look at the enterprise to sales, we see a ratio of 19.18. The receivables turnover for the company is 50.57for trailing twelve months and the total asset turnover is 0.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.23.
Conclusion
To sum up, Verastem Inc (VSTM) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
